We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+9.23%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$4.22B
AUM Growth
-$1.2B
Cap. Flow
-$1.32B
Cap. Flow %
-31.23%
Top 10 Hldgs %
40.53%
Holding
893
New
143
Increased
129
Reduced
82
Closed
273
Avg Time Held Equity + Options
3.6 quarters
Top 10 Avg Time Held Equity + Options
0.7 quarters
Top 20 Avg Time Held Equity + Options
0.8 quarters
Avg Time Held Equity only
3.7 quarters
Top 10 Avg Time Held Equity only
0.7 quarters
Top 20 Avg Time Held Equity only
0.8 quarters

Sector Composition

Rank Sector Weight
1 Financials 22.21%
2 Healthcare 21.3%
3 Technology 18.64%
4 Miscellaneous 15.12%
5 Industrials 5.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
PLMJ icon
151
DELISTED
Plum Acquisition Corp. III Class A Ordinary Shares
PLMJ
$3.91M 0.09%
378,097
– –
2021 Q3
6 quarters
SCUA
152
DELISTED
Sculptor Acquisition Corp I
SCUA
$3.88M 0.09%
370,698
– –
2022 Q1
4 quarters
AHRN
153
DELISTED
Ahren Acquisition Corp
AHRN
$3.86M 0.09%
370,698
– –
2022 Q2
3 quarters
BPAC icon
154
DELISTED
Bullpen Parlay Acquisition Company Class A Ordinary Share
BPAC
$3.86M 0.09%
370,698
– –
2022 Q1
4 quarters
PORT
155
DELISTED
Southport Acquisition Corporation
PORT
$3.86M 0.09%
370,698
– –
2022 Q1
4 quarters
ADBE icon
156
Adobe
ADBE
$94.3B
$3.85M 0.09%
+10,000
New +$3.55M
2023 Q1
0 quarters
STI icon
157
Solidion Technology
STI
$51.1M
$3.85M 0.09%
7,282
– –
2022 Q2
3 quarters
PLAO icon
158
DELISTED
Patria Latin American Opportunity Acquisition Corp. Class A Ordinary Shares
PLAO
$3.84M 0.09%
364,093
– –
2022 Q2
3 quarters
IONS icon
159
Ionis Pharmaceuticals
IONS
$7.52B
$3.84M 0.09%
107,489
+29,119
+37% +$1.09M
2022 Q1
4 quarters
CFFS icon
160
DELISTED
CF Acquisition Corp. VII Class A Common Stock
CFFS
$3.84M 0.09%
370,698
– –
2022 Q1
4 quarters
SMAR icon
161
DELISTED
Smartsheet Inc.
SMAR
$3.82M 0.09%
+80,000
New +$3.48M
2023 Q1
0 quarters
NHI icon
162
National Health Investors
NHI
$3.18B
$3.82M 0.09%
74,081
+54,813
+284% +$2.99M
2022 Q2
3 quarters
TMCI icon
163
Treace Medical Concepts
TMCI
$257M
$3.67M 0.09%
145,559
+2,250
+2% +$52.8K
2022 Q1
4 quarters
DAL icon
164
Delta Air Lines
DAL
$54B
$3.66M 0.09%
104,855
– –
2020 Q2
11 quarters
INSM icon
165
Insmed
INSM
$22B
$3.6M 0.09%
211,340
+35,588
+20% +$691K
2022 Q1
4 quarters
O icon
166
Realty Income
O
$51.3B
$3.56M 0.08%
+56,264
New +$3.65M
2023 Q1
0 quarters
PDD icon
167
Pinduoduo
PDD
$116B
$3.53M 0.08%
46,479
-4,802
-9% -$434K
2022 Q3
2 quarters
ACEL icon
168
Accel Entertainment
ACEL
$893M
$3.45M 0.08%
378,313
– –
2020 Q1
12 quarters
VICI icon
169
VICI Properties
VICI
$25.2B
$3.44M 0.08%
+105,560
New +$3.49M
2023 Q1
0 quarters
GCTS icon
170
GCT Semiconductor Holding
GCTS
$186M
$3.43M 0.08%
330,834
– –
2022 Q1
4 quarters
MNTN icon
171
DELISTED
Everest Consolidator Acquisition Corporation
MNTN
$3.39M 0.08%
324,361
– –
2022 Q1
4 quarters
MTVC
172
DELISTED
Motive Capital Corp II
MTVC
$3.38M 0.08%
324,361
– –
2022 Q1
4 quarters
FR icon
173
First Industrial Realty Trust
FR
$7.88B
$3.38M 0.08%
63,457
+12,243
+24% +$638K
2018 Q3
18 quarters
PHM icon
174
Pultegroup
PHM
$21.4B
$3.36M 0.08%
57,593
+40,399
+235% +$2.18M
2022 Q4
1 quarter
NCLH icon
175
Norwegian Cruise Line
NCLH
$7.15B
$3.33M 0.08%
247,861
– –
2021 Q3
6 quarters

Similar funds

UBS O'Connor's Q1 2023 Portfolio in Review

As of Q1 2023, UBS O'Connor held 893 positions worth $4.22B, down 22% from $5.42B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

UBS O'Connor withdrew a net $1.32B in Q1 2023, closing 273 positions and reducing 82 holdings. Its most notable exit was STORE Capital Corporation, an estimated $414M position sold in full.

By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 26% a quarter earlier, followed by Healthcare and Technology.

Against the trend, UBS O'Connor opened a new position in Oak Street Health, Inc. worth $25.3M.

  • UBS O'Connor's largest Q1 2023 buy was Oak Street Health, Inc.: 6,537,297 shares worth $25.3M.
  • UBS O'Connor added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2023, an estimated $189M increase.
  • UBS O'Connor's biggest Q1 2023 reduction was Activision Blizzard, cutting an estimated $196M.
  • UBS O'Connor fully exited STORE Capital Corporation in Q1 2023, selling an estimated $414M.
  • UBS O'Connor's ten largest holdings make up 41% of its $4.22B portfolio in Q1 2023.
  • UBS O'Connor opened 143 new positions and closed 273 in Q1 2023.
  • UBS O'Connor's portfolio value fell 22% quarter-over-quarter to $4.22B.

Based on UBS O'Connor's 13F filing for Q1 2023, filed 15 May 2023.